Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial

VALOR-HCM Investigators

Research output: Contribution to journalArticlepeer-review

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)1041-1045
Number of pages5
JournalJournal of the American College of Cardiology
Volume84
Issue number11
DOIs
StatePublished - Sep 10 2024

Keywords

  • Kansas City Cardiomyopathy Questionnaire
  • mavacamten
  • obstructive HCM

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this